Compugen

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Compugen and other ETFs, options, and stocks.

About CGEN

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases.

CEO

Anat Cohen-Dayag

CEOAnat Cohen-Dayag

Employees

Employees74

Headquarters

Holon, Tel Aviv

HeadquartersHolon, Tel Aviv

Founded

1993

Founded1993

Employees

Employees74

CGEN Key Statistics

Market cap

147.75M

Market cap147.75M

Price-Earnings ratio

-10.22

Price-Earnings ratio-10.22

Dividend yield

—

Dividend yield—

Average volume

183.49K

Average volume183.49K

High today

$1.62

High today$1.62

Low today

$1.54

Low today$1.54

Open price

$1.61

Open price$1.61

Volume

151.49K

Volume151.49K

52 Week high

$2.66

52 Week high$2.66

52 Week low

$1.13

52 Week low$1.13

People also own

Based on the portfolios of people who own CGEN. This list is generated using Robinhood data, and it’s not a recommendation.